tradingkey.logo

Bio Rad Laboratories Inc

BIOb
311.350USD
+8.200+2.70%
Close 11/03, 16:00ETQuotes delayed by 15 min
8.40BMarket Cap
LossP/E TTM

Bio Rad Laboratories Inc

311.350
+8.200+2.70%

More Details of Bio Rad Laboratories Inc Company

Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.

Bio Rad Laboratories Inc Info

Ticker SymbolBIOb
Company nameBio Rad Laboratories Inc
IPO dateMar 17, 1980
CEOMr. Norman D. Schwartz
Number of employees7700
Security type- -
Fiscal year-endMar 17
Address1000 Alfred Nobel Dr
CityHERCULES
Stock exchange- -
CountryUnited States of America
Postal code94547
Phone15107247000
Websitehttps://www.bio-rad.com/
Ticker SymbolBIOb
IPO dateMar 17, 1980
CEOMr. Norman D. Schwartz

Company Executives of Bio Rad Laboratories Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Norman D. Schwartz
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
431.47K
+15.22%
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
--
--
Mr. Jonathan P. (Jon) Divincenzo
Mr. Jonathan P. (Jon) Divincenzo
President, Chief Operating Officer
President, Chief Operating Officer
--
--
Ms. Colleen Corey
Ms. Colleen Corey
Executive Vice President, Global Human Resources
Executive Vice President, Global Human Resources
--
--
Mr. Jeffrey L. (Jeff) Edwards
Mr. Jeffrey L. (Jeff) Edwards
Independent Director
Independent Director
--
--
Mr. Roop K. Lakkaraju
Mr. Roop K. Lakkaraju
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Lead Independent Director
Lead Independent Director
--
--
Mr. Arnold A. Pinkston
Mr. Arnold A. Pinkston
Independent Director
Independent Director
--
--
Mr. Edward Chung
Mr. Edward Chung
Vice President - Investor Relations
Vice President - Investor Relations
--
--
Mr. James J. Barry
Mr. James J. Barry
Executive Vice President, President - Life Science Group
Executive Vice President, President - Life Science Group
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Norman D. Schwartz
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
431.47K
+15.22%
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
--
--
Mr. Jonathan P. (Jon) Divincenzo
Mr. Jonathan P. (Jon) Divincenzo
President, Chief Operating Officer
President, Chief Operating Officer
--
--
Ms. Colleen Corey
Ms. Colleen Corey
Executive Vice President, Global Human Resources
Executive Vice President, Global Human Resources
--
--
Mr. Jeffrey L. (Jeff) Edwards
Mr. Jeffrey L. (Jeff) Edwards
Independent Director
Independent Director
--
--
Mr. Roop K. Lakkaraju
Mr. Roop K. Lakkaraju
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--

Revenue Breakdown

Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
No Data
By RegionUSD
Name
Revenue
Proportion
United States
266.90M
40.96%
Europe
217.20M
33.33%
APAC
126.40M
19.40%
Other
41.10M
6.31%
By Business
By Region
No Data

Shareholding Stats

Updated: Wed, Apr 2
Updated: Wed, Apr 2
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Blue Raven Partners, L.P.
80.10%
Alice N. Schwartz Revocable Trust
8.63%
Schwartz (Norman D)
8.51%
Schwartz (Steven D)
0.75%
Allison (Schwartz)
0.08%
Other
1.92%
Shareholders
Shareholders
Proportion
Blue Raven Partners, L.P.
80.10%
Alice N. Schwartz Revocable Trust
8.63%
Schwartz (Norman D)
8.51%
Schwartz (Steven D)
0.75%
Allison (Schwartz)
0.08%
Other
1.92%
Shareholder Types
Shareholders
Proportion
Corporation
88.74%
Individual Investor
9.35%
Investment Advisor
0.05%
Other
1.87%

Institutional Shareholding

Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
15
3.05K
0.06%
-2.88K
2025Q2
21
4.97M
98.11%
-2.90K
2025Q1
24
4.97M
98.11%
-3.68K
2024Q4
24
4.98M
98.13%
-2.55K
2024Q3
23
4.98M
98.13%
-1.92K
2024Q2
24
4.97M
98.11%
-3.25K
2024Q1
25
4.98M
98.12%
-3.79K
2023Q4
26
4.98M
98.03%
-84.86K
2023Q3
26
4.96M
97.77%
-85.38K
2023Q2
26
4.95M
97.50%
-98.97K
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Blue Raven Partners, L.P.
4.06M
80.08%
--
--
May 01, 2025
Alice N. Schwartz Revocable Trust
437.51K
8.63%
--
--
May 01, 2025
Schwartz (Norman D)
374.47K
7.39%
+114.00
+0.03%
Feb 24, 2025
Schwartz (Steven D)
38.24K
0.75%
+57.00
+0.15%
Feb 24, 2025
Allison (Schwartz)
4.00K
0.08%
+57.00
+1.45%
Feb 24, 2025
CSS, LLC
1.09K
0.02%
--
--
Jun 30, 2025
Buckingham Strategic Wealth, LLC
760.00
0.01%
--
--
Jun 30, 2024
Morgan Stanley Smith Barney LLC
692.00
0.01%
--
--
Jun 30, 2025
Wells Fargo Advisors
170.00
0%
--
--
Jun 30, 2025
Whittier Trust Company
160.00
0%
--
--
Jun 30, 2025
View more

Related ETFs

Name
Proportion
No Data

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Split

Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
KeyAI